Promoting Pioneering Research: The Inaugural President’s Scholars
For many early-career investigators, the only limit to their high-potential research is the funding needed to support it. Imagine, then, what an unrestricted gift of $100,000 per year for three years could mean—to their laboratories, to medicine, and, potentially, to patient care.
Convening Leading Experts to Tackle a Rare Liver Disease
Patients with a rare chronic liver disease have new reason for hope thanks to the launch of a first-of-its-kind center at Brigham and Women’s Hospital aimed at identifying and pursuing life-saving treatments.
Hair Cells Hold New Hope for Hearing Loss
Since the damage or loss of hair cells, specialized inner-ear cells that transmit sound vibrations via electrical signals to the brain, is responsible for hearing loss, restoring those hair cells could restore hearing.
Accelerating Vaccines’ Trajectory, from Protein to Patient
Within the Vaccine and Immunotherapy Center at Massachusetts General Hospital, efforts are underway to accelerate the development of vaccines aimed at protecting populations from global health threats.
For Burn Victims and Patients Awaiting Organs, Hope in Animal Cells
An unexpected source—pig skin—could be the key to treating burn victims, and may hold the key to addressing the shortage of transplantable organs. In a trial at Massachusetts General Hospital (MGH), burn specialists were the world’s first to use live-cell, genetically engineered pig skin to temporarily close a burn wound in a human patient.
A Case for the Health Care Proxy
For a seriously ill patient without a health care proxy agent—an individual legally permitted to make decisions for a patient who is incapacitated—their condition can be not only painful for family members, but logistically untenable.